Literature DB >> 26585137

Purification of Histone Lysine Methyltransferase SMYD2 and Co-Crystallization with a Target Peptide from Estrogen Receptor α.

Yuanyuan Jiang1, Joshua Holcomb1, Nicholas Spellmon1, Zhe Yang2.   

Abstract

Methylation of estrogen receptor α by the histone lysine methyltransferase SMYD2 regulates ERα chromatin recruitment and its target gene expression. This protocol describes SMYD2 purification and crystallization of SMYD2 in complex with an ERα peptide. Recombinant SMYD2 is overexpressed in Escherichia coli cells. After release from the cells by French Press, SMYD2 is purified to apparent homogeneity with multiple chromatography methods. Nickel affinity column purifies SMYD2 based on specific interaction of its 6×His tag with the bead-immobilized nickel ions. Desalting column is used for protein buffer exchange. Gel filtration column purifies SMYD2 based on molecular size. The entire purification process is monitored and analyzed by SDS-polyacrylamide gel electrophoresis. Crystallization of SMYD2 is performed with the hanging drop vapor diffusion method. Crystals of the SMYD2-ERα peptide complex are obtained by microseeding using seeding bead. This method can give rise to large size of crystals which are suitable for X-ray diffraction data collection. X-ray crystallographic study of the SMYD2-ERα complex can provide structural insight into posttranslational regulation of ERα signaling.

Entities:  

Keywords:  Chromatography; Crystallization; Gel filtration; Nickel affinity; Protein purification; Seeding; X-ray crystallography

Mesh:

Substances:

Year:  2016        PMID: 26585137     DOI: 10.1007/978-1-4939-3127-9_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Molecular Cloning and Purification of the Protein Lysine Methyltransferase SMYD2 and its Co-crystallization with a Target Peptide from Estrogen Receptor Alpha.

Authors:  Yingxue Zhang; Zhe Yang
Journal:  Methods Mol Biol       Date:  2022

2.  New open conformation of SMYD3 implicates conformational selection and allostery.

Authors:  Nicholas Spellmon; Xiaonan Sun; Wen Xue; Joshua Holcomb; Srinivas Chakravarthy; Weifeng Shang; Brian Edwards; Nualpun Sirinupong; Chunying Li; Zhe Yang
Journal:  AIMS Biophys       Date:  2016-12-20

3.  Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma.

Authors:  Wenchao Xu; Fulian Chen; Xiao Fei; Xiaoqing Yang; Xiaofei Lu
Journal:  Med Sci Monit       Date:  2018-10-15

Review 4.  Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer.

Authors:  Eid Alshammari; Ying-Xue Zhang; Zhe Yang
Journal:  World J Gastroenterol       Date:  2022-08-07       Impact factor: 5.374

5.  SAXS analysis of a soluble cytosolic NgBR construct including extracellular and transmembrane domains.

Authors:  Joshua Holcomb; Maysaa Doughan; Nicholas Spellmon; Brianne Lewis; Emerson Perry; Yingxue Zhang; Lindsey Nico; Junmei Wan; Srinivas Chakravarthy; Weifeng Shang; Qing Miao; Timothy Stemmler; Zhe Yang
Journal:  PLoS One       Date:  2018-01-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.